New glimmer of hope: Medaustron revolutionizes cancer treatment!

New glimmer of hope: Medaustron revolutionizes cancer treatment!

In the renowned Cancer Treatment and Research Center Medaustron in Wiener Neustadt, there are exciting news: An innovative treatment method for eye tumors has been offered since November. This was emphasized several times today at a press conference by LH deputy Stephan Pernkopf, Mayor Klaus Schneeberger and the medical director Professor Eugen B. HUG. "Over 2,700 patients have been helped since the commissioning of Medausttron in 2016," said Pernkopf and added that quick and effective treatments are decisive, especially with a cancer diagnosis.

It was also announced that the state of Lower Austria will support the Medaustron study department with 1.8 million euros in the next four years. "Research that saves life" is the motto that runs through all efforts. Professor Hug said that the center's goal is to reduce the waiting times for the patients to a minimum in order to enable immediate therapy. For many affected people, Medaustron is equal to the last hope because it is one of the few European centers that specialize in proton radiation therapy, especially for surrounding countries where such forms of treatment are not yet available.

patient information and support

MedaUtron not only offers the latest treatment, but also support for the patients themselves. Relatives can contact the clinic on behalf of the clinic, provided that the person concerned has a declaration of consent, as medaustron.at . Various communication channels are available for therapy inquiries, including email and telephone. In addition, support is offered by accommodation for patients who are planning to arrive and all the necessary information is provided online.

Overall, MedaUtron impressively shows how modern cancer research contributes to significantly improving the quality of life of those affected. The networking of medical and technical know-how is of central importance here in order to be able to offer patients the best possible treatment.